Natures Sunshine Products vs Usana Health Sciences
Usana Health Sciences is the larger business, with $925m of revenue in fiscal 2025 against $480m for Natures Sunshine Products (1.9 times as much). Usana Health Sciences grew faster (8.3% against 5.7%). Natures Sunshine Products kept more of each dollar of sales as profit: a net margin of 4.1% against 1.2%. Natures Sunshine Products carries less debt relative to equity (0.0% against 2.6%).
| Latest fiscal year | Natures Sunshine ProductsNATR, 2025 | Usana Health SciencesUSNA, 2025 |
|---|---|---|
| Revenue | $480m | $925m |
| Revenue growth | 5.7% | 8.3% |
| Net income | $19.5m | $10.8m |
| Operating margin | 5.2% | 4.0% |
| Net margin | 4.1% | 1.2% |
| Return on equity | 12.1% | 2.0% |
| Free cash flow | $28.8m | $8.5m |
| Cash | $93.9m | $158m |
| Total debt | $0 | $14.0m |
| Debt to equity | 0.0% | 2.6% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $16.3m | $27.5m |
| Employees | — | 1,570 |
| Market value | $213m | $276m |
| Price vs our value range | Below our value range | Below our value range |
| Moat score | 68 (Moderate) | 72 (Strong) |
| Insider trades, 12 months | 14 buys, 12 sales | 0 buys, 16 sales |